EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE

被引:0
|
作者
Dimopoulos, Christina
Hung, Kenneth
Proctor, Deborah
Ruggiero, Eilzabeth
Al-Bawardy, Badr
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
23
引用
收藏
页码:S32 / S33
页数:2
相关论文
共 50 条
  • [1] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    [J]. INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
  • [2] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675
  • [3] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [4] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    [J]. Drugs, 2021, 81 : 333 - 347
  • [5] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    [J]. DRUGS, 2021, 81 (03) : 333 - 347
  • [6] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Mark Fleisher
    Jan Marsal
    Scott D. Lee
    Laura E. Frado
    Alyssa Parian
    Burton I. Korelitz
    Brian G. Feagan
    [J]. Digestive Diseases and Sciences, 2018, 63 : 825 - 833
  • [7] Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    [J]. Drugs, 2021, 81 : 1697 - 1697
  • [8] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [9] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [10] VEDOLIZUMAB INDUCES DE NOVO EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kim, Su Bin
    Diaz, Liege I.
    Calmet, Fernando
    Quintero, Maria A.
    Schwartz, Ingrid
    Abreu, Maria T.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360